Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6776)
All Articles published online
|
Publishing Process of This Article
|
Aug 6, 2019 (publication date) through May 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Daher R, Lefebvre T, Puy H, Karim Z. Extrahepatic hepcidin production: The intriguing outcomes of recent years. World J Clin Cases 2019; 7(15): 1926-1936 [PMID: 31423425 DOI: 10.12998/wjcc.v7.i15.1926] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i15/1926.htm |
| Number | Citing Articles |
| 1 |
Zachary J. Hawula, Daniel F. Wallace, V. Nathan Subramaniam, Gautam Rishi. Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis. Pharmaceuticals 2019; 12(4): 170 doi: 10.3390/ph12040170
|
| 2 |
Runyu Liang, Qiang Tang, Wenjing Song, Mei Zhang, Lili Teng, Yuying Kang, Luwen Zhu, Feng Zhang. Electroacupuncture Preconditioning Reduces Oxidative Stress in the Acute Phase of Cerebral Ischemia-Reperfusion in Rats by Regulating Iron Metabolism Pathways. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/3056963
|
| 3 |
Isabella Zanella, Giulia Paiardi, Diego Di Lorenzo, Giorgio Biasiotto. Iron Absorption in Celiac Disease and Nutraceutical Effect of 7-Hydroxymatairesinol. Mini-Review. Molecules 2020; 25(9): 2041 doi: 10.3390/molecules25092041
|
| 4 |
Poonam Sagar, Stanzin Angmo, Rajat Sandhir, Vikas Rishi, Hariom Yadav, Nitin Kumar Singhal. Effect of hepcidin antagonists on anemia during inflammatory disorders. Pharmacology & Therapeutics 2021; 226: 107877 doi: 10.1016/j.pharmthera.2021.107877
|
| 5 |
Ignasi Mora, Francesc Puiggròs, Florenci Serras, Katherine Gil-Cardoso, Xavier Escoté. Emerging models for studying adipose tissue metabolism. Biochemical Pharmacology 2024; 223: 116123 doi: 10.1016/j.bcp.2024.116123
|
| 6 |
Stanko Petrović, Dino Tarabar, Danica Ćujić, Dusica Stamenkovic, Marijana Petrović, Nemanja Rančić, Vesna Subota, Nenad Perišić, Mihailo Bezmarević. A Prospective Observational Study Analyzing the Diagnostic Value of Hepcidin-25 for Anemia in Patients with Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2024; 25(7): 3564 doi: 10.3390/ijms25073564
|
| 7 |
Yuki Hamada, Eiichi Hirano, Koji Sugimoto, Keizo Hanada, Taiichi Kaku, Naoki Manda, Kenichi Tsuchida. A farewell to phlebotomy—use of placenta-derived drugs Laennec and Porcine for improving hereditary hemochromatosis without phlebotomy: a case report. Journal of Medical Case Reports 2022; 16(1) doi: 10.1186/s13256-021-03230-5
|
| 8 |
Feng Lin, Alex Tuffour, Guijie Hao, Frank Addai Peprah, Aixia Huang, Yang Zhou, Haiqi Zhang. Distinctive modulation of hepcidin in cancer and its therapeutic relevance. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1141603
|
| 9 |
Mariangela Malerba, Carole Peyssonnaux. Rôle de l’hepcidine dans les infections cutanées. médecine/sciences 2020; 36(3): 222 doi: 10.1051/medsci/2020037
|
| 10 |
Mete Ucdal, Ayse Burus, Basak Celtikci, Hatice Yasemin Balaban. A novel brick on the wall of non-alcoholic fatty liver disease (NAFLD): Nuclear receptor coactivator 4 (NCOA4). Medical Hypotheses 2023; 181: 111203 doi: 10.1016/j.mehy.2023.111203
|
| 11 |
Yuki Hamada, Eiichi Hirano. Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis. 2023; doi: 10.5772/intechopen.107221
|